These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24954322)

  • 1. Optical coherence tomographic observation of morphological features of neointimal tissue after drug-eluting stent implantation.
    Lee SY; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2014 Jul; 55(4):944-52. PubMed ID: 24954322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.
    Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between pre-procedural plaque morphology and patterns of in-stent neointimal hyperplasia at 1-year follow-up in patients treated with new-generation drug-eluting stents: An optical coherence tomography based analysis.
    Shi SY; Chen KL; Gu J; Xu C; Chen QR; Chen YQ; Xu T; Ke HY; Sun JH; Ye F
    J Interv Cardiol; 2018 Dec; 31(6):737-746. PubMed ID: 30251273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound.
    Kwon SW; Kim BK; Kim TH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Am Heart J; 2011 Feb; 161(2):367-72. PubMed ID: 21315221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-stent neointimal characteristics and late neointimal response after drug-eluting stent implantation: A preliminary observation.
    Fukuhara K; Okura H; Kume T; Yamada R; Neishi Y; Uemura S
    J Cardiol; 2016 May; 67(5):437-41. PubMed ID: 26276105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: Optical coherence tomography and histopathology validation study.
    Imanaka T; Fujii K; Hao H; Shibuya M; Saita T; Kawakami R; Fukunaga M; Kawai K; Tamaru H; Miki K; Horimatsu T; Sumiyoshi A; Nishimura M; Hirota S; Masuyama T; Ishihara M
    Int J Cardiol; 2016 Oct; 221():1043-7. PubMed ID: 27447812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis.
    Jang JY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Atherosclerosis; 2015 Oct; 242(2):553-9. PubMed ID: 26318104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal course of neointimal hyperplasia following drug-eluting stent implantation: a serial follow-up optical coherence tomography analysis.
    Lee SY; Hong MK; Mintz GS; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Int J Cardiovasc Imaging; 2014 Aug; 30(6):1003-11. PubMed ID: 24807243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological validation of frequency domain optical coherence tomography for the evaluation of neointimal formation after a novel polymer-free sirolimus-eluting stent implantation.
    Fu Q; Hu H; Chen W; Tan Z; Li L; Wang D; Chen B
    Int J Clin Exp Pathol; 2015; 8(9):11068-75. PubMed ID: 26617825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between in-stent neointimal characteristics and native coronary artery disease progression.
    Jung HW; Lim C; Bae HJ; Lee JH; Lee YJ; Kim JS; Lee SJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
    PLoS One; 2021; 16(4):e0247359. PubMed ID: 33891606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin receptor blockers on neointimal characteristics in angina patients requiring stent implantation: optical coherence tomography analysis.
    Cho JY; Hong SJ; Lim DS
    BMC Cardiovasc Disord; 2017 Nov; 17(1):278. PubMed ID: 29141596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.
    Hou J; Jia H; Liu H; Han Z; Yang S; Xu C; Schmitt J; Zhang S; Yu B; Jang IK
    Int J Cardiovasc Imaging; 2012 Dec; 28(8):1879-86. PubMed ID: 22422037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents.
    Legutko J; Gil RJ; Buszman PE; Kaluza GL; Mintz GS; Roleder T; Krol M; Wojdyla R; Pawlowski T; Brzezinski M; Kondys M; Skwarna B; Jakala J; Zasada W; Partyka L; Dudek D
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):302-309. PubMed ID: 29027737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
    Ko YG; Kim DM; Cho JM; Choi SY; Yoon JH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):715-23. PubMed ID: 21656060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of very early neointimal coverage post drug-eluting stent implantation using optical coherence tomography].
    Wang TJ; Yang YJ; Xu B; Xu L; Sun ZW; Ma C; Tang Y; Tian Y; Yuan WM; Chu Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):747-51. PubMed ID: 23141086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of postintervention and nine-month luminal enlargement after treatment of drug-eluting in-stent restenosis with a drug-eluting balloon.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Am J Cardiol; 2014 May; 113(9):1468-73. PubMed ID: 24607028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.